跳至主要内容
临床试验/CTRI/2023/05/052901
CTRI/2023/05/052901尚未招募3 期

Clinical validation of Unani pharmacopoeial formulation Habb-e-Pachlona in Su al-Hadm (Dyspepsia)

Central Council for Research in Unani Medicine (CCRUM), New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients of either sex in the age group of 18-60
  • 2. Patients meeting the Rome III diagnostic criteria for PDS

排除标准

  • 1. Presence of GI ulcer, erosive gastritis, atrophic gastritis, severe dysplasia of gastric mucosa or suspicious malignant lesion based on clinical diagnosis.
  • 2. Having overlap syndrome combined with gastro esophageal reflux disease or irritable bowel syndrome
  • 3. Having alarm symptoms (weight loss, black or tar stool, dysphasia, etc.)
  • 4. Having any systemic disease (diseases of heart, lung, liver or kidney) or mental illness
  • 5. History of surgery related with the gastrointestinal tract more than six months ago
  • 6. Taking drugs which may affect the gastro intestinal tract, such as non-steroidal anti-inflammatory drugs and aspirin
  • 7. Known Allergy to the experimental medications
  • 8. Pregnant and breastfeeding
  • 9. Refusing to sign the informed consent

研究者

发起方
Central Council for Research in Unani Medicine (CCRUM), New Delhi

相似试验